| Pharmacological and Molecular Approaches to Investigate Selected Drug in Model of Ischemia-Reperfusion Injury in Streptozotocin Induced Diabetic Rats | Prof Dharamvir Singh Arya, All India Institute of Medical Sciences (AIIMS), New Delhi | 2018 | Bristol-Myers Squibb (BMS) Company, USA | Pharmaceutical Sciences, Life Sciences & Biotechnology, Medical Sciences |
| Tuberculosis: Learning the Impact of Nutrition (TB LION) | Dr Subitha L, Associate Professor, Jawaharlal Institute of Post Graduate Medical Education and Research (JIPMER), Puducherry | 2018 | Boston University School of Medicine (BUSM) - Warren Alpert Foundation (WAF), USA | Life Sciences & Biotechnology, Medical Sciences |
| Association of Lipid mediators of inflammation with TB treatment outcomes | Dr Padma Chandrasekaran, Scientist, National Institute for Research in Tuberculosis (ICMR-NIRT), Tamil Nadu | 2018 | Gilead Sciences, Inc., USA | Life Sciences & Biotechnology, Medical Sciences |
| Cryptococcal Infections in Non HIV Infected Hosts: A Prospective International Study (MSG-11) | Dr Arunaloke Chakrabarti, Professor and Head, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh | 2018 | Gilead Sciences, Inc., USA | Life Sciences & Biotechnology, Medical Sciences |
| A randomized, Double-blind, Placebo and Active controlled, Multicenter, Phase 3 Study to Access the Efficacy and Safety of Filgotinib Administered for 52 Weeks Alone and in Combination with Methotrexate (MTX) to Subjects with Moderately to Severely Active Rheumatoid Arthritis who Are Naive to MTX Therapy | Dr Uma Kumar, Professor & Head, All India Institute of Medical Sciences (AIIMS), New Delhi | 2018 | Gilead Sciences, Inc., USA | Life Sciences & Biotechnology, Medical Sciences |
| A randomized, double-blind, placebo and active controlled, multicenter, phase 3 study to access the efficacy and safety of Filgotinib administered for 52 weeks in combination with Methotrexate (MTX) to subjects with moderately to severely active rheumatoid arthritis, who have an inadequate response to methotrexate | Dr Uma Kumar, Professor & Head, All India Institute of Medical Sciences (AIIMS), New Delhi | 2018 | Gilead Sciences, Inc., USA | Life Sciences & Biotechnology, Medical Sciences |
| Flipping to empower adolescents for sexual and reproductive health | Dr Pratibha Singh, Professor and Head, All India Institute of Medical Sciences (AIIMS), Rajasthan | 2018 | Grand Challenges, Canada | Life Sciences & Biotechnology, Medical Sciences |
| Scaling Early Childhood development at Anganwadi centers in India- Transition to Scale | Dr Abhay Motiramji Gaidhane, Director, Datta Meghe Institute of Medical Sciences (DMIMS), Maharashtra | 2018 | Grand Challenges, Canada | Life Sciences & Biotechnology, Medical Sciences |
| Promoting Family Integrated Early Child Development (during 1000 days) in Urban Slums (Fine Child 3-3-1000) | Dr Manoja Kumar Das, Director, The INCLEN Trust International, New Delhi | 2018 | Grand Challenges, Canada | Life Sciences & Biotechnology, Medical Sciences |
| Diagnostic evaluation of plasma GFAP for the rapid differentiation between ischemic stroke and intracerebral hemorrhage | Dr Jeyaraj Durai Pandian, Professor and Head, Christian Medical College (CMC), Punjab | 2018 | Goethe University, Germany | Life Sciences & Biotechnology, Medical Sciences |